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The majority of patients with epilepsy live in developing countries but there is limited information on status epilepticus (SE)
from these regions. We evaluated the clinical profile and predictors of poor outcome in a group of Chinese patients with SE.
Patients with SE were ascertained from the medical, intensive care and emergency departments of a large urban hospital from
1996 to 2001. Factors for poor outcome, defined as death or morbidity as measured by deterioration in functional status using the
Glasgow Outcome Score were analysed in a multivariate logistic regression model. A total of 107 episodes of SE occurring in
Chinese patients were studied. The three most common underlying causes were cerebrovascular disease, metabolic derangement
and anti-convulsant withdrawal but alcohol-related SE was infrequent. Twenty-six percent had worsened functional ability and
the mortality rate was 16%. Predictors of poor outcome were older age (odds ratio (OR) = 1.04, 95% CI 1.01–1.07), delay
in treatment (OR = 3.52, 95%CI 1.01–12.18), SE due to cerebrovascular disease (OR = 9.73, 95% CI 1.58–59.96) and CNS
infection (OR = 30.27, 95% CI 3.14–292.19).
© 2003 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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INTRODUCTION
Status epilepticus (SE) is the result of a variety of
insults to the central nervous system and is a common
neurological emergency1. An estimated 5–61 patients
per 100 000 residents develop SE in the United States
and Western Europe every year2–6. Age, seizure
type, aetiology, female sex, duration of SE and time
elapsed from onset to treatment have been reported as
prognostic factors2–12. So far no clinical study of this
condition in Chinese adults has been reported. We in-
vestigated the demographic data, clinical features and
aetiology among patients who were admitted with SE
to an urban Chinese hospital as well as independent
factors for poor outcome.
METHODS
We collected data from consecutive patients over 12
years old who were admitted with SE to the Prince
of Wales Hospital in Hong Kong, China. This is
the only government acute hospital in the district
in which it serves; locally less than 2% of patients
with epilepsy-related hospitalisations are admitted to
private institutions13. We performed a retrospective
search of patients from January 1996 to Decem-
ber 1999; from January 2000 to December 2001,
we prospectively included cases admitted with a
diagnosis of SE. Patients were identified from the
records of the electrodiagnostic unit and from the
hospital’s computerised information system record-
ing the admission/discharge records of the emergency
and medical departments and the intensive care
unit (ICU). (International Classification of Disease
(ICD)-9 codes 345.2, 345.3, 345.7 and 780.39.) SE
was defined as (1) continuous seizure activity lasting
30 minutes or more or (2) recurrent seizure activ-
ity lasting 30 minutes or more without full return of
consciousness.
After establishing that the criteria for the diagnosis
of SE was satisfied, the following information was
recorded using a standardised data sheet: demograhic
details, history of co-existing medical diseases, history
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of epilepsy and anti-epileptic drug use, seizure type,
aetiology, results of laboratory, brain imaging and
electroencephalography (EEG) investigations, du-
ration of ICU stay and outcome. All patient files
and records were reviewed by two study physi-
cians. Seizure types were categorised according to
the International Classification of Epileptic Seizures
based on scrutiny of case notes in patients ascer-
tained retrospectively and on information from wit-
nesses, nursing and physician staff in patients in
the prospective group14. The episodes were classi-
fied as overt generalised convulsive, non-convulsive,
partial motor and myoclonic SE. EEG confirmation
was needed to diagnose non-convulsive status epilep-
ticus (NCSE). Non-compliance with anti-epileptic
drugs required laboratory or historical support. Pa-
tients who did not meet the definition of SE were
excluded. Aetiology was defined as the presence of
a remote or acute symptomatic injury that was as-
sumed to have caused the episode, following the
modified classification of Hauser and Kurland15.
Similar to previous studies, etiologic causes were
categorised as alcohol-related, anti-epileptic drug
non-compliance, cerebrovascular disease, central ner-
vous system infection, toxic-metabolic disorders,
trauma and tumours. If there was no clinical, lab-
oratory or radiological evidence sufficient to sup-
port a specific cause, the aetiology was labelled as
idiopathic.
All patients were treated according to established
hospital management guidelines, based on pub-
lished recommendations with intravenous diazepam
or lorazepam followed by phenytoin loading of
15–20 mg/kg as first line anti-convulsive therapy16.
Second-line agents were not standardised and con-
sisted of midazolam, propofol, phenobarbitone or
thiopentone infusions. Delay in treatment was de-
fined here as initiation of anti-epileptic drugs (AED)
30 minutes after the onset of SE as reported by wit-
nesses or medical personnel. Patients with recurrent
or continuous seizures for over 60 minutes despite ad-
equate therapy in accordance with the protocol were
regarded as being in refractory SE.
Functional status as defined by the Glasgow Out-
come Score (GOS) was recorded in all patients at the
time of discharge17. This widely used scoring system
consists of five degrees of handicap (GOS): (1) death
within the first month; (2) vegetative state; (3) severe
disability—conscious but requiring constant supervi-
sion; (4) moderate disability—neurological impair-
ment, but independent; (5) good recovery (leading an
independent life, with or without minimal neurolog-
ical impairment). Poor outcome was defined as death
or functional deterioration of one or more points on
the GOS among survivors at discharge as compared
with pre-admission.
Statistical analysis
All data were analysed with SPSS 9.0 software for
Windows (Chicago, IL). In the univariate analysis,
age was analysed as a continuous variable, and the
presence of pre-existing epilepsy, seizure type, aetiol-
ogy and delay in treatment were analysed as categor-
ical variables. Independent t-test or one-way ANOVA
was used for continuous variables and chi-squared or
Fisher’s exact test for categorical variables. The pre-
dictive factors for poor outcome were determined in
the multivariate logistic regression model after adjust-
ment for age, gender, pre-existing epilepsy, seizure
type, delay in treatment and aetiology. Statistic signif-
icance was regarded at the 0.05 level.
RESULTS
A total of 115 episodes of SE were identified of which
107 fulfilled the entry criteria; one patient had two
episodes of SE. Eight were excluded because of the
final diagnosis of psychogenic seizures, duration of
seizure under 30 minutes (two cases each) and mis-
classification (four cases). The demographic details,
seizure types and outcomes were similar in both the
retrospective and prospective groups and, therefore,
the data were pooled for statistical analysis.
The mean age of the included patients was
44.8 ± 19.8 years old; all were local ethnic Chinese
residents. Fifty-three percent were male. Sixty-one
cases (57%) had pre-existing epilepsy. Delay in treat-
ment was recorded in 31 patients (29%) and refrac-
tory SE developed in 34 (32%). The most common
aetiology was cerebrovascular disease (27%), fol-
lowed by idiopathic (18%), metabolic derangement
(16%) and anti-epileptic drug non-compliance (14%)
(Fig. 1). SE was secondary to an acute symptomatic
event such as new onset stroke or meningitis in 46
(43%) patients. Seizure types consisted of gener-
alised tonic-clonic in 81 patients (76%), partial in
18 (17%), non-convulsive in 5 (5%) and myoclonus
in 3 (3%). Myoclonic seizures were secondary to
post-hypoxic encephalopathy in all three patients in
the study.
The mean duration of hospitalisation was 16.4± 20
days. Eighty-two patients (77%) required admission
to the ICU, with a mean period of 3.6± 5.9 days, and
65 patients (61%) were ventilated with a mean dura-
tion 2.7± 5.6 days. Sixty-two patients (57%) made a
full recovery, 28 (26%) had a deterioration in func-
tional ability at discharge compared with pre-morbid
and 17 (16%) had died. The most common residual
deficit was cognitive impairment and persistent hemi-
paresis. Nine variables identified in the univariate
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Fig. 1: Causes of status epilepticus among Hong Kong Chinese.
analysis as significant variables were included in
the multivariate model: older age, a prior history of
epilepsy, non-convulsive and myoclonic seizures, SE
due to cerebrovscular disease, CNS infection, tumour,
alcohol and delay in treatment (Table 1). After cor-
rection for the above factors, increased age (OR 1.04,
95% CI 1.01–1.07), SE due to cerebrovascular dis-
ease (OR 9.73, 95% CI 1.58–59.96), CNS infection
(OR 30.70, 95% CI 3.14–292.19) and delay in treat-
ment (OR 3.52, 95% CI 1.01–12.18) were associated
with poor outcome (Table 1).
Table 1: Predictors of poor outcome following status epilepticus (n = 107).
Unadjusted odds ratios (95% CI) P Adjusted odds ratios (95% CI) P
Age 1.02 (1.01–1.04) 0.01 1.04 (1.01–1.07) 0.01
Gender
Men 1 reference 1 reference
Women 1.16 (0.54–2.51) 0.70 1.16 (0.39–3.34) 0.79
Pre-existing epilepsy
No 1 reference 1 reference
Yes 0.20 (0.13–0.69) 0.004 1.21 (0.34–4.31) 0.77
Seizure types
Generalised 1 reference 1 reference
Partial 1.17 (0.95–1.46) 0.11 0.85 (0.22–3.24) 0.81
Complex partial 1.11 (0.99–1.24) 0.047 6.17 (0.32–122.49) 0.23
Myoclonus 1.12 (0.98–1.29) 0.06 928.36 (0–3525) 0.74
Aetiology
Idiopathic 1 reference 1 reference
Cerebrovascular disease 5.57 (1.45–21.41) 0.001 9.73 (1.58–59.96) 0.01
CNS infection 3.82 (1.11–13.17) 0.002 30.27 (3.14–292.19) 0.003
Metabolic 4.25 (1.17–15.46) 0.004 3.52 (0.43–29.25) 0.24
Non-compliance 0.82 (0.35–1.95) 1.00 0.57 (0.03–11.28) 0.71
Tumour 2.98 (0.91–9.74) 0.01 9.22 (0.96–87.08) 0.05
Trauma 1.16 (0.50–2.66) 1.00 1.32 (0.07–22.82) 0.85
Alcoholic 1.89 (0.70–5.07) 0.07 9.28 (0.45–192.42) 0.15
Delay in treatment
No 1 reference 1 reference
Yes 3.72 (1.54–8.92) 0.005 3.51 (1.01–12.18) 0.04
DISCUSSION
The importance of the underlying cause of SE in
determining outcome is increasingly recognised; pa-
tients ideally should be categorised into good and
poor prognostic groups for the purposes of clinical
trials and treatment. A history of acute or remote
cerebrovascular disease was the most common dis-
order causing SE in our study while cerebrovascular
disease and CNS infection were associated with a
higher risk of poor outcome. These two diagnoses
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have also been reported to carry a higher case fatality
in a large population-based series from California6.
Compared with previous reports, alcohol-related SE
is not a common cause in this series which is prob-
ably due to the lower prevalence of alcohol use and
dependence in Chinese communities; this may be
one reason for the lower incidence of generalised
convulsive SE in Asians6. Age is an important factor
in the distribution of aetiology. In studies looking at
older patients, strokes, tumours are more frequent
while in children, febrile convulsions and CNS infec-
tions are more common. The percentage of idiopathic
cases may vary depending on the thoroughness of
investigation.
There are a number of limitations to the current
series. The partly retrospective nature of this study
may have introduced bias; errors in coding or diag-
nosis may have lead to under-ascertainment of cases.
In particular, NCSE may be missed without a strong
index of suspicion and easily accessible EEG. Gen-
eralised SE is, however, less likely to be missed or
misdiagnosed by clinicians. We have tried to min-
imise underestimation by searching for cases of SE
from different databases. Although this study was
conducted at a single public hospital, in our locality
the vast majority of patients with acute neurological
emergencies are treated in government hospitals. An-
other limitation is the sample size, as reflected in the
large confidence intervals in some of the variables;
additional factors associated with poor outcome may
be identified with a larger sample population.
SE is more common in the elderly and mortality is
also higher in this age group2–6, 18–22. With the age-
ing of the population in China, the incidence of SE,
as well as its complications is expected to rise. The
range in reported fatality rates may be due to different
patient populations under review; in studies reporting
higher mortality rates, the mean age of patients with
SE are higher. In our centre, overall 22% of patients
had a drop in functional ability while the mortality
was 16%, which is in keeping with experience from
other studies and which underscores the severity of
this condition. As with many clinical studies, we
looked at mortality on discharge; a longer period of
evaluation would be expected produce a higher fig-
ure. In the only long-term population-based survey of
SE, Logroscino found that at 10 years the cumulative
mortality rate of patients who survived the first 30
days was 43%, a three-fold increase compared with
the general population22. From clinical and experi-
mental data the longer the duration of SE, the more
difficult it becomes to control seizures4, 23. Similarly,
we found that delay in initiating treatment is associ-
ated with poor outcome. The results from this series
highlights the importance of rapid diagnosis and
treatment.
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